¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"T cell factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
cell mass
¼¼Æ÷µ¢ÀÌ, ¼¼Æ÷±«
cell membrane
¼¼Æ÷¸·
cell membrane permeability
¼¼Æ÷¸·Åõ°ú¼º
cell organelle
¼¼Æ÷¼Ò±â°ü
cell respiration
¼¼Æ÷È£Èí
cell strain
¼¼Æ÷ÁÖ
cell substitution
¼¼Æ÷´ëü, Ç÷±¸´ëü
cell surface receptor
¼¼Æ÷Ç¥¸é¼ö¿ëü
cell swelling
¼¼Æ÷Á¾Ã¢
cell-associated antibody
¼¼Æ÷¿¬°üÇ×ü
cell-bound antibody
¼¼Æ÷°áÇÕÇ×ü
cell-fixed antibody
¼¼Æ÷°áÇÕÇ×ü
cell-mediated cytolysis
¼¼Æ÷¸Å°³¼¼Æ÷¿ëÇØ
cell-mediated cytotoxicity
¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
cell-mediated hypersensitivity
¼¼Æ÷¸Å°³°ú¹Î¼º
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
chromophilic cell
»ö¼Òµë¼¼Æ÷, È£»ö¼Ò¼¼Æ÷
chromophobic cell
»ö¼Ò¾Èµë¼¼Æ÷
ciliated cell
¼¶¸ð¼¼Æ÷, ÀÜÅм¼Æ÷
clear cell
Åõ¸í¼¼Æ÷
clear cell carcinoma
Åõ¸í¼¼Æ÷¾ÏÁ¾
clear cell hidradenoma
Åõ¸í¼¼Æ÷¶¡»ùÁ¾
clear cell sarcoma
Åõ¸í¼¼Æ÷À°Á¾
columnar cell
¿øÁÖ¼¼Æ÷
columnar absorptive cell
±âµÕÈíÂø¼¼Æ÷
committed cell
¾ô¸Ç¼¼Æ÷, ¼öÀÓ¼¼Æ÷
complex cell
º¹ÇÕ¼¼Æ÷
cone cell
¿ø»Ô¼¼Æ÷
cone cell layer
¿ø»Ô¼¼Æ÷Ãþ
connective tissue cell
°áÇÕÁ¶Á÷¼¼Æ÷
continuous cell line
¹«ÇÑÁõ½Ä¼º¼¼Æ÷ÁÖ, ¿¬¼Ó°è´ë¼¼Æ÷ÁÖ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
alpha cell
¾ËÆÄ¼¼Æ÷
alpha cell
¾ËÆÄ¼¼Æ÷(¡á¬øà)
alpha cell tumor
¾ËÆÄ ¼¼Æ÷Á¾(¡á¬øàðþ)
amacrine cell
¾Æ¸¶Å©¸° ¼¼Æ÷
amacrine cell
¹«Ãà»è¼¼Æ÷
ameboid cell
¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
aneuploid cell
À̼ö¼º¼¼Æ÷
anitschkow cell
¾Æ´ÏÄ¡ÄÚ¿ì¼¼Æ÷(¡á¬øà)
annular elastotic giant cell granuloma
ȯ»ó ź·Â ¼¶À¯¼º °Å´ë¼¼Æ÷ À°¾ÆÁ¾
anoxic cell
¹«»ê¼Ò¼¼Æ÷
anti-idiotypic T suppressor cell
Ç×°³º°Æ¯ÀÌÇü ¾ïÁ¦T¼¼Æ÷
antibody dependent cell mediated cytotoxicity
Ç×üÀÇÁ¸ ¼¼Æ÷¸Å°³ ¼¼Æ÷µ¶¼º.
antibody forming cell
Ç×ü»ý»ê¼¼Æ÷(ù÷ô÷ßæß§á¬øà).
antibody producing cell
Ç×ü»ý»ê¼¼Æ÷
antigen presenting cell
Ç׿øÁ¦½Ã¼¼Æ÷.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
inhibition(-tory) factor, macrophage migration
´ë½Ä¼¼Æ÷ À¯ÁÖÀúÁöÀÎÀÚ
insulin-like growth factor
Àν¶¸°À¯»ç¼ºÀåÀÎÀÚ
intensity factor
°µµÀÎÀÚ
intrinsic factor
³»ÀμºÀÎÀÚ, ³»Àμº¿ä¼Ò, °íÀ¯ÀÎÀÚ
intrinsic factor
³»ÀÎÀÚ
intrinsic factor =IF
³»ÀÎÀÚ(Ò®ì×í).
intrinsic factor(if)
³»ÀÎÀÚ(Ò®ì×í)
islet-activation factor
¶û°Ô¸£Çѽº»ù Ȱ¼ºÀÎÀÚ, ¹éÀÏÇØ±Õµ¶¼Ò
isodose shift factor
µî¼±·®À̵¿°è¼ö
kerma factor
Ä¿¸¶ °è¼ö
ketogenic factor
ÄÉÅæÃ¼Çü¼ºÀÎÀÚ(¡ô÷û¡à÷ì×í).
labile factor
ºÒ¾ÈÁ¤ÀÎÀÚ, ºÒ¾ÈÁ¤¿ä¼Ò.
lactogenic factor
ÃÖÀ¯ÀÎÀÚ(¡ì×í).
lactogenic factor
À¯ÁóºÐºñÀ¯µµÀÎÀÚ(¡ì×í).
leucocyte inhibition factor
¹éÇ÷±¸¾ïÁ¦ÀÎÀÚ.
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½